Summary by Moomoo AI
Kozi Pharma-B (02171.HK) submitted its disclosure report the next day on June 12, 2024, disclosing its shareholding changes. The report shows that the company repurchased shares between May 31 and June 12, 2024, with a total of 1,498,000 shares repurchased, accounting for 0.26% of the issued shares. The repurchased shares will be cancelled. In addition, the company confirms that all share repurchases have been authorized by the board of directors and comply with relevant listing rules and laws. Based on the latest share repurchase, the company will enter into a one-month suspension period until July 12, 2024, during which no new shares may be issued or any existing shares sold.